Log in to add personal notes on this page.
Long-chain fatty acids (14 to 20 carbons) cannot cross the mitochondrial membranes on their own, so the carnitine shuttle carries them in for beta-oxidation. Short- and medium-chain fats enter mitochondria directly, which is why medium-chain triglycerides are used to bypass the CPT1A, CACT, and CPT2 blocks on this page. During fasting, illness, or prolonged exercise, liver, heart, and muscle depend on this route, so a block shows up exactly when fat should take over as fuel.
- Carnitine enters the cell: the plasma membrane carnitine transporter OCTN2 (SLC22A5) takes up carnitine from blood and reclaims it from kidney filtrate. Blocked in carnitine uptake defect.
- long-chain acyl-CoA + carnitine → long-chain acylcarnitine: carnitine palmitoyltransferase 1A (CPT1A), outer mitochondrial membrane, the first and rate-limiting step. The liver and kidney isoform. Blocked in CPT1A deficiency.
- Acylcarnitine crosses the inner membrane: carnitine-acylcarnitine translocase (SLC25A20) moves it into the matrix in exchange for free carnitine. Blocked in CACT deficiency.
- long-chain acylcarnitine → long-chain acyl-CoA + free carnitine: carnitine palmitoyltransferase 2 (CPT2), inner membrane, matrix side. Blocked in CPT2 deficiency.
- The acyl-CoA enters beta-oxidation, and in the liver the acetyl-CoA it yields becomes ketone bodies.
- Carnitine uptake defect: the kidney wastes carnitine into urine and cells hold too little. Plasma free carnitine (C0) is very low. Fasting hypoglycemia, dilated cardiomyopathy, and myopathy follow, and high-dose oral carnitine replaces what is missing. A low newborn C0 can instead be the mother's own deficiency, so she is tested too.
- CPT1A deficiency: acylcarnitines cannot form, so free carnitine is high and every acylcarnitine species is low. Liver ketogenesis fails during fasting, giving hypoketotic hypoglycemia and liver dysfunction; heart and muscle use a different isoform and are usually spared.
- CACT deficiency: long-chain acylcarnitines (C16, C18:1) pile up outside the matrix with low C0. The severe neonatal form brings hypoglycemia, hyperammonemia, and arrhythmia; ventricular tachycardia with cardiac arrest is the most common cause of death.
- CPT2 deficiency: the same acylcarnitine pattern as CACT deficiency. The common myopathic form (p.Ser113Leu) gives attacks of muscle pain and rhabdomyolysis after prolonged exercise, fasting, cold, or fever; lethal neonatal and infantile hepatocardiomuscular forms also occur.
- Free carnitine (C0) with the long-chain acylcarnitines (C14 to C18) sorts all four. Low C0 with low long-chain species is the transporter defect, with high urinary carnitine because the kidney cannot reclaim it. High C0 with low long-chain species is CPT1A deficiency, because carnitine is never loaded onto fat; the C0/(C16+C18) ratio is the screening marker. Low C0 with high long-chain species is CACT or CPT2 deficiency, because acylcarnitines form and then stall.
- CACT and CPT2 deficiency share that profile, so gene testing or enzyme studies separate them.
- Ketones are low in every one of these during a fasting crisis, the hypoketotic hypoglycemia that marks a fat oxidation defect.
CPT1 works in the 1iver, which is why heart and muscle are spared. CACT is CArdiac: neonatal arrhythmia and sudden death.